alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4835 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
                                H. R. 4835

    To extend the pilot program on off-base transition training for 
                         veterans and spouses.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 18, 2018

 Ms. Esty of Connecticut (for herself and Mr. Poe of Texas) introduced 
 the following bill; which was referred to the Committee on Veterans' 
  Affairs, and in addition to the Committee on Armed Services, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL

 
    To extend the pilot program on off-base transition training for 
                         veterans and spouses.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Job Training through Off-Base 
Opportunities and Local Support for Veterans Act'' or the ``Job TOOLS 
for Veterans Act''.

SEC. 2. PILOT PROGRAM FOR OFF-BASE TRANSITION TRAINING FOR VETERANS AND 
              SPOUSES.

    (a) Extension of Pilot Program.--Subsection (a) of section 301 of 
the Dignified Burial and Other Veterans' Benefits Improvement Act of 
2012 (Public Law 112-260; 10 U.S.C. 1144 note) is amended--
            (1) by striking ``During the two-year period beginning on 
        the date of the enactment of this Act, the'' and inserting 
        ``During the five-year period beginning on the date of the 
        enactment of the Job TOOLS for Veterans Act, the''; and
            (2) by striking ``to assess the feasibility and 
        advisability of providing such program to eligible individuals 
        at locations other than military installations''.
    (b) Locations.--Subsection (c) of such section is amended--
            (1) in paragraph (1), by striking ``not less than three and 
        not more than five States'' and inserting ``not less than 50 
        locations in States (as defined in section 101(20) of title 38, 
        United States Code)''; and
            (2) in paragraph (2), by striking ``at least two'' and 
        inserting ``at least 20''.
    (c) Conforming Repeal.--Subsection (f) of such section is repealed.
                                 <all>
```
##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 8-K
 CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 Date of Report (Date of the earliest event reported): June 17, 2008
 Valeant Pharmaceuticals International
  Delaware
    
    1-11397
    
    33-0628076(State or other jurisdiction of
    
    (Commission File Number)
    
    (I.R.S Employerincorporation or organization)
    
    
    
    Identification No.)
 One Enterprise
Aliso Viejo, California 92656   (949) 461-6000
  o
    
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)o
    
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)o
    
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))o
    
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))




---



TABLE OF CONTENTS  Item 8.01 Other EventsItem 9.01 Financial Statements and ExhibitsSIGNATURESINDEX TO EXHIBITSEXHIBIT 99.1    Table of Contents  
 Item 8.01 Other Events
  
 Item 9.01 Financial Statements and Exhibits.




---



##### Table of Contents



SIGNATURES
  VALEANT PHARMACEUTICALS INTERNATIONALDate: June 17, 2008
    By:
    /s/ Peter J. BlottPeter J. BlottExecutive Vice President  and
Chief Financial Officer




---



##### Table of Contents



INDEX TO EXHIBITS
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from Swift Energy
Pension Partners  1995-B,  Ltd.'s balance sheet and statement of operations con-
tained in its Form 10-K for the year ended December 31, 1997 and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-END>                                   DEC-31-1997
<CASH>                                         600,825
<SECURITIES>                                   0
<RECEIVABLES>                                  115,823
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               724,091
<PP&E>                                         2,236,845
<DEPRECIATION>                                 (150,695)
<TOTAL-ASSETS>                                 2,810,241
<CURRENT-LIABILITIES>                          8,402
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     2,801,839
<TOTAL-LIABILITY-AND-EQUITY>                   2,810,241
<SALES>                                        208,860
<TOTAL-REVENUES>                               327,090
<CGS>                                          0
<TOTAL-COSTS>                                  98,153<F1>
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                172,017
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            172,017
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   172,017
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
<FN>
<F1>Includes  lease  operating  expenses,  production  taxes  and  depreciation,
depletion and  amortization  expense.  Excludes general and  administrative  and
interest expense.
</FN>
        


</TABLE>
**EXHIBIT 32.1**
**CERTIFICATION**
     Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of1934, as amended (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the UnitedStates Code (18 U.S.C. § 1350), Hollings C. Renton, Chairman of the Board, President and ChiefExecutive Officer of Onyx Pharmaceuticals, Inc. (the “Company”), hereby certifies that, to the bestof his knowledge:
**1.**  The Company’s Annual Report on Form 10-K for the period ended December 31, 2004, to whichthis Certification is attached as Exhibit 32.1 (the “Annual Report”), fully complies with therequirements of Section 13(a) or Section 15(d) of the Exchange Act; and
**2.**  The information contained in the Annual Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.
Dated: March 15, 2005    /s/ Hollings C. Renton   Hollings C. Renton Chairman of the Board, President and Chief Executive Officer (Principal Executive and Financial Officer)     
A signed original of this written statement required by Rule 13(a)-14(b) of the Exchange Act andSection 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350) has beenprovided to Onyx Pharmaceuticals, Inc. and will be retained by Onyx Pharmaceuticals, Inc. andfurnished to the Securities and Exchange Commission or its staff upon request.
“This certification accompanies the Form 10-K to which it relates, is not deemed filed with theSecurities and Exchange Commission and is not to be incorporated by reference into any filing ofOnyx Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities ExchangeAct of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective ofany general incorporation language contained in such filing.”
DISMISS ; and Opinion Filed July 24, 2015. 

# S

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05

- 14

- 01448

- CV
DELORES RUBIO, AS PE RSONAL REPRESENTATIV E OF

THE ESTATE OF WILLIE PEDRO RUBIO, JR. , Appellant V. EXCELL ELECTRICAL CO NTRACTORS, INC. , Appellee
On Appeal from the County Court at Law No. 4 Dallas County, Texas Trial Court Cause No. CC

- 14

- 01239

- D



### MEMORANDUM OPINION Before Justices Francis, Lang

- Miers, and Whitehill Opinion by Justice Lang

- Miers Before the Court is appellant’s unopposed motion to dismiss the appeal. Appellant has
informed the Court that the issues on appeal have been resolved and the appeal is now moot.
Accordingly, we grant appellant’s motion and dismiss the appeal. See T EX

. R. A PP

. P. 42.1(a)(1).

141448F.P05 /Elizabeth Lang

- Miers/ ELIZABETH LANG

- MIERS JUSTICE– 2

– 

# S

Court of Appeals Fifth District of Texas at Dallas
JUDGMENT

DELORES RUBIO, AS PERSONAL REPRESENTATIVE OF THE ESTATE OF WILLIE PEDRO RUBIO, JR., Appellant

No. 05

- 14

- 01448

- CV V.

EXCELL ELECTRICAL CONTRACTORS, INC., Appellee On Appeal from the County Court at Law No. 4, Dallas County, Texas. Trial Court Cause No. CC

- 14

- 01239

- D. Opinion delivered by Justice Lang

- Miers. Justices Francis and Whitehill, participating.

In accordance with this Court’s opinion of this date, the appeal is DISMISSED

.
It is ORDERED that appellee EXCELL ELECTRICAL CONTRACTORS, INC. recover its costs of this appeal from appellant DELO RES RUBIO, AS PERSONAL REPRESENTATIVE OF THE ESTATE OF WILLIE PEDRO RUBIO, JR..

Judgment entered this 24th day of July, 2015.
EXHIBIT 21.1

                       AVIATION COMPANY AND SUBSIDIARIES

                       LIST OF SUBSIDIARIES OF REGISTRANT


Aviation Sales Operating Company (wholly-owned subsidiary)

         Aviation Sales Bearings Company (wholly-owned subsidiary of Aviation
         Sales Operating Company)

Aviation Sales Leasing Company (wholly-owned subsidiary)

         Aviation Sales SPS I, Inc. (wholly-owned subsidiary of Aviation
         Sales Leasing Company)

Aviation Sales Finance Company (wholly-owned subsidiary)

Aviation Sales Manufacturing & Repair Company ("ASM&R") (wholly-owned
subsidiary)

         AVS/Kratz-Wilde Machine Company (wholly-owned subsidiary of ASM&R)

         Apex Manufacturing, Inc. (wholly-owned subsidiary of ASM&R)

         Aerocell Structures, Inc. (wholly-owned subsidiary of ASM&R)

         Caribe Aviation, Inc. (wholly-owned subsidiary of ASM&R)

                  Aircraft Interior Design, Inc. (wholly-owned subsidiary of
                  Caribe Aviation, Inc.)

Aviation Sales Company FSC, Ltd. (wholly-owned subsidiary)
<TABLE> <S> <C>

<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                       5,794,622
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                 11,454,573
<INVESTMENTS-CARRYING>                      22,101,977
<INVESTMENTS-MARKET>                        22,143,036
<LOANS>                                    106,371,241
<ALLOWANCE>                                    982,198
<TOTAL-ASSETS>                             148,549,488
<DEPOSITS>                                 133,930,016
<SHORT-TERM>                                   500,000
<LIABILITIES-OTHER>                            580,245
<LONG-TERM>                                    443,697
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     5,725,535
<OTHER-SE>                                   7,377,140
<TOTAL-LIABILITIES-AND-EQUITY>             148,549,488
<INTEREST-LOAN>                              8,664,936
<INTEREST-INVEST>                            2,088,919
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                            10,753,855
<INTEREST-DEPOSIT>                           4,866,837
<INTEREST-EXPENSE>                           4,879,599
<INTEREST-INCOME-NET>                        5,874,256
<LOAN-LOSSES>                                  280,000
<SECURITIES-GAINS>                               1,283
<EXPENSE-OTHER>                              4,303,238
<INCOME-PRETAX>                              1,852,348
<INCOME-PRE-EXTRAORDINARY>                   1,103,038
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,103,038
<EPS-PRIMARY>                                      .81
<EPS-DILUTED>                                      .80
<YIELD-ACTUAL>                                    4.52
<LOANS-NON>                                     62,632
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                               783,366
<CHARGE-OFFS>                                   86,399
<RECOVERIES>                                     5,231
<ALLOWANCE-CLOSE>                              982,198
<ALLOWANCE-DOMESTIC>                           982,198
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
EXHIBIT 31.1

                           CERTIFICATION OF PRESIDENT
                         AND PRINCIPAL FINANCIAL OFFICER

I, Harry Chauhan, certify that:

1. I have reviewed this quarterly report on Form 10-QSB/A of Atlantic Wine
Agencies, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and have:

      a) designed such disclosure controls and procedures to ensure that
      material information relating to the registrant, including its
      consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this quarterly report is
      being prepared;

      b) evaluated the effectiveness of the registrant's disclosure controls and
      procedures as of a date within 90 days prior to the filing date of this
      quarterly report (the "Evaluation Date"); and


      c) presented in this quarterly report my conclusions about the
      effectiveness of the disclosure controls and procedures based on our
      evaluation as of the Evaluation Date;

5. I have disclosed, based on our most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons
performing the equivalent functions):

      a) all significant deficiencies in the design or operation of internal
      controls which could adversely affect the registrant's ability to record,
      process, summarize and report financial data and have identified for the
      registrant's auditors any material weaknesses in internal controls; and

      b) any fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant's internal
      controls; and


6. I have indicated in this quarterly report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of my most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.

Date: November 23, 2004

/s/ Harry Chauhan
---------------------------------------------
Name: Harry Chauhan
Title: President and Chief Financial Officer
Exhibit 31.2


I, Jaren Chan Eng Ann, CEO, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Myoffiz,
Inc.;

2. Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other
financial information included in this quarterly report, fairly
present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the
periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) for the registrant and we have:

      a) designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant is made known to us by others within the Corporation,
particularly during the period in which this quarterly report is
being prepared;

      b) evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as
of the end of the period covered by this report based on such
evaluation; and

      c) disclosed in this report any change in the registrant's
internal control over financial reporting that occurred during the
registrant's most recent fiscal quarter that has materially affected,
or is reasonably likely to materially affect, the registrant's
internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal
control over financial reporting, to the registrant's auditors and
the audit committee of registrant's board of directors (or persons
performing the equivalent function):

      a) all significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant's
ability to record, process, summarize and report financial
information; and

      b) any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant's
internal control over financial reporting.






   March 14, 2004                 /s/    Jaren Chan Eng Ann
                                  --------------------------
                                  Jaren Chan Eng Ann
                                  Chief Executive Officer
Exhibit 31.4

CERTIFICATIONS

I, C. Patrick Machado, certify that:

1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K/A of Medivation, Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.



|                  |  |  |  |  |  |                                                   
|----------------- |  |  |  |  |  | --------------------------------------------------
|Date: May 2, 2011 |  |  |  |  |  | /s/ C. Patrick Machado                            
|                  |  |  |  |  |  | C. Patrick Machado                                
|                  |  |  |  |  |  | Chief Business Officer and Chief Financial Officer
<PAGE>   1
                                                                 EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in Amendment
No. 1 to the Registration Statement (Form S-3 No. 333-16371) and related
Prospectus of DepoTech Corporation for the registration of 1,500,000 shares of
its common stock and to the incorporation by reference therein of our report
dated February 16 1996, with respect to the financial statements of DepoTech
Corporation included in its Annual Report (Form 10-K) for the year ended
December 31, 1995, filed with the Securities and Exchange Commission.


                                                        ERNST & YOUNG LLP

San Diego, California
December 26, 1996
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 154 Introduced in Senate (IS)]

  1st Session
                                 S. 154

   To prohibit the expenditure of appropriated funds on the Advanced 
                            Neutron Source.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 5, 1995

 Mr. Bumpers (for himself, Mr. Bradley, Mr. Feingold, Mr. Harkin, Mr. 
  Kohl, Mr. Simon, and Mr. Wellstone) introduced the following bill; 
  which was read twice and referred to the Committee on Appropriations

_______________________________________________________________________

                                 A BILL

 
   To prohibit the expenditure of appropriated funds on the Advanced 
                            Neutron Source.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Advanced Neutron Source Termination 
Act of 1995''.

SEC. 2. TERMINATION OF THE ADVANCED NEUTRON SOURCE.

    (a) Prohibition.--Effective 90 days after the date of enactment of 
this section, no appropriated funds shall be available for the 
planning, construction and operation of the Advanced Neutron Source.
    (b) Unexpended Funds.--Any funds appropriated for the advanced 
Neutron Source that remain unexpended and unobligated 90 days after the 
date of enactment of this section shall be credited to the general 
revenues of the United States Treasury.
                                 <all>
```